My Locations
Part of the Duke Cancer Institute
Part of the Duke Cancer Institute
About Me
I was drawn to the field of oncology because cancer is a terrifying diagnosis for most people. It is one of those health issues that make people very nervous. I find great satisfaction working with cancer patients to help allay their fears and provide the best care possible. For me, it is rewarding to work with individuals who express so much courage in overcoming a difficult diagnosis. It is very rare that a patient comes alone to an appointment. Usually they have a spouse, son or daughter, a brother or sister, or a mother or father accompanying them. I spend a lot of time answering family member’s questions, who often provide a significant amount of care and support for their loved one. My job is to help educate both the patient and the family and to formulate a plan by which we can provide comprehensive care for all of the patient’s needs.
- Professor of Radiation Oncology, Radiation Oncology 2020
- Member of the Duke Cancer Institute, Duke Cancer Institute 2017
Call for an Appointment
Areas of Expertise
- Leukemia
- Lymphoma
- Lung Cancer
- Metastatic Brain and Spine Tumors
- Chronic Lymphocytic Leukemia
- Myeloma
- Mesothelioma
- Thymoma
Ratings and Reviews
The ratings and reviews are based on patient responses to the overall provider rating question from the survey. The question reads: “Using any number from 0 to 10, where 0 is the worst provider possible and 10 is the best provider possible, what number would you use to rate this provider?” Responses are converted to a 5-point rating system and applied consistently to all providers. Learn more about our survey process. Patients who see some types of providers receive a different version of the patient satisfaction survey. Those results are not available on DukeHealth.org.
Training and Education
Clinical Focus and Research
I am involved in clinical trials optimizing the use of radiation therapy for both lung cancer and non-Hodgkin lymphoma. Patients are offered participation in such trials if they meet eligibility criteria. Multiple other studies are ongoing evaluating different aspects of treatment and outcomes in each of the disease sites I treat- lung cancer, Hodgkin lymphoma, non-Hodgkin lymphoma, and mesothelioma.
-
NRG-LU008 for locally advanced non-small cell lung cancerIRB# PRO00116500 , NCT# NCT05624996
- Knowledge-based Tutoring for Knowledge-based Radiation Therapy awarded by Varian Medical Systems, Inc. 2020 - 2022
- Dorth, J. A., J. P. Chino, L. R. Prosnitz, L. F. Diehl, A. W. Beaven, R. E. Coleman, and C. R. Kelsey. “The impact of radiation therapy in patients with diffuse large B-cell lymphoma with positive post-chemotherapy FDG-PET or gallium-67 scans.” Ann Oncol 22, no. 2 (February 2011): 405–10. https://doi.org/10.1093/annonc/mdq389.
- Kelsey, Chris R., Srinivasan Mukundan, Zhiheng Wang, Carol A. Hahn, Brian J. Soher, and John P. Kirkpatrick. “Assessing neurotoxicity from the low-dose radiation component of radiosurgery using magnetic resonance spectroscopy.” Neuro Oncol 12, no. 2 (February 2010): 145–52. https://doi.org/10.1093/neuonc/nop040.
- Higgins, Kristin, Junzo P. Chino, Lawrence B. Marks, Neal Ready, Thomas A. D’Amico, Robert W. Clough, and Chris R. Kelsey. “Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer.” Int J Radiat Oncol Biol Phys 75, no. 5 (December 1, 2009): 1462–67. https://doi.org/10.1016/j.ijrobp.2009.01.069.
- Champ, C. E., and C. R. Kelsey. “Lymphomas.” In Target Volume Definition in Radiation Oncology, 379–403, 2024. https://doi.org/10.1007/978-3-031-45489-9_17.
- Diaz, A. K., and C. R. Kelsey. “Role of Postoperative Radiation Therapy in Non-Small Cell Lung Cancer.” In Medical Radiology, Part F1269:471–82, 2023. https://doi.org/10.1007/174_2021_274.
- Voorhees, T. J., E. V. Bowers, C. R. Kelsey, Y. Park, and A. W. Beaven. “Cutaneous T-cell lymphoma: Mycosis fungoides and sezary syndrome.” In Novel Therapeutics for Rare Lymphomas, 221–46, 2019. https://doi.org/10.1007/978-3-030-25610-4_14.
- Tseng, Y. D., P. Stevenson, B. Nguyen, D. C. Li, D. Y. Lee, I. Paydar, J. Nakashima, et al. “Impact of Myc-Altered Pathology on Radiation Therapy Efficacy Among Patients With Relapsed/Refractory Large-B Cell Lymphoma: A Collaborative Study by ILROG.” In International Journal of Radiation Oncology Biology Physics, 121:1237–47, 2025. https://doi.org/10.1016/j.ijrobp.2024.11.072.
- Iyengar, P., B. G. Allen, C. R. Kelsey, J. Holmlund, M. Brookes, and E. C. Moser. “GRECO-1: Phase 1/2 Study of Stereotactic Body Radiation Therapy (SBRT) With or Without GC4711 for Early Stage, Centrally Located or Large Non-Small Cell Lung Cancer (NSCLC).” In International Journal of Radiation Oncology, Biology, Physics, 111:e471, 2021. https://doi.org/10.1016/j.ijrobp.2021.07.1313.
- Liveringhouse, C., N. B. Lam, S. A. Rosenberg, T. J. Dilling, G. Macmillan, A. Chiappori, E. B. Haura, et al. “Prospective Phase I/II Study of Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable NSCLC.” In International Journal of Radiation Oncology, Biology, Physics, 111:S3–4, 2021. https://doi.org/10.1016/j.ijrobp.2021.07.043.
Insurance Accepted
Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below.
-
Aetna
- Aetna Choice POS, Aetna Choice POS II
- Aetna Elect Choice HMO, Aetna Open Access Elect Choice
- Aetna Health Network Only, Aetna Health Network Option
- Aetna HMO
- Aetna Limited Benefit Insurance PPO
- Aetna Managed Choice POS
- Aetna Medicare Assure Plan (HMO D-SNP)
- Aetna Medicare Eagle Plan (PPO)
- Aetna Medicare Essential Plan (PPO)
- Aetna Medicare Value Plan (HMO)
- Aetna Open Access HMO, Open Access Aetna Select, Aetna Open Access Managed Choice
- Aetna Open Choice PPO
- Aetna PCP Coordinated POS Plan
- Aetna Quality Point of Service (QPOS)
- Aetna Select HMO
- Aetna Traditional Choice
- Aetna Voluntary Indemnity Group Plan
- Aetna Whole Health – Duke WakeMed WKCC
- Aetna/CVS Health
-
Ambetter
- Ambetter of North Carolina
-
Blue Cross Blue Shield of NC
- Blue Advantage
- Blue Medicare (HMO, PPO)*
- Blue Options (123, PPO, HSA)
- Blue Select
- NC State Employees Health Plan
-
*Duke HomeCare and Hospice does not participate in the plan.
-
Cigna
- Cigna Behavioral Health (*Limited eligibility)
- Cigna Choice Plus
- Cigna Connect Individual Family Plan
- Cigna Open Access
- Cigna Open Access Plus
-
*Please call Cigna Behavioral Heath to see if the provider is participating in your plan.
-
Duke Group Plans
- Duke Basic
- Duke Select
-
Experience Health
- Experience Health Medicare Advantage (HMO) Plan
- Gateway Health Alliance
- Healthgram
-
Humana
- Humana Choice (PPO)
- Humana Choice - Medicare Advantage (PPO)
- Humana ChoiceCare - Medicare Advantage (PPO)
- Humana Gold Choice - Medicare Advantage (PFFS)
- Humana Gold Plus - Medicare Advantage (HMO)
- Humana Medicare Advantage Group Plan - NC State Retirees
- MedCost
-
Medicare
- First Medicare Direct
- Medicare Part A
- Medicare Part B
-
NC Medicaid
- AmeriHealth Caritas North Carolina
- Carolina Complete Health
- Healthy Blue
- NC Medicaid Direct
- WellCare of North Carolina
-
TRICARE
- TRICARE Prime
- TRICARE Prime Remote
- TRICARE Select
-
United Healthcare
- AARP Medicare Advantage Plan 2 (HMO-POS)
- AARP Medicare Complete (HMO, PPO)*
- AARP Medicare Complete Essential (HMO)*
- All Savers Alternate Funding
- All Savers Fully Insured
- United Healthcare (HMO, PPO, POS)**
- United Healthcare Charter/Charter Balance/Charter Plus
- United Healthcare Choice/Choice Plus
- United Healthcare Core/Core Essential
- United Healthcare Navigate/Navigate Plus/Navigate Balanced
- United Healthcare Option PPO
- United Healthcare Passport Connect Choice/Choice Plus
- United Healthcare Passport Connect Options PPO
- United Healthcare Select/Select Plus
- United Healthcare Shared Services - Harvard Pilgrim/UHC Options PPO Network
- United Medical Resources (UMR)
-
*Duke HomeCare and Hospice and mental health providers do not participate with the plan.
-
**Duke Health does not participate in UHC plans on the Health Insurance Marketplace.
Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.
External Relationships
- Colgate-Palmolive
- Johnson & Johnson